hematopoietic stem cell gene therapy (HSC-GT)

Kyowa Kirin is a Japan-based global specialty pharmaceutical company that contributes to human health and well-being worldwide through innovative drug discovery and global commercialization. Driven by state-of-the-art antibody technologies, it focuses on core therapeutic areas of oncology, nephrology, central nervous system and immunology, as well as bone & mineral diseases, hematological diseases and rare diseases.

Read more

antibody technologiesdrug discoveryglobal commercializationopen innovation and partnershipsproduction and quality assurance